Company Contact: TSO, Inc., R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: info@tso3.com; TSO, Inc., Glen Kayll, CFO, Tel: 418 651-0003, Email: info@tso3.com; Investor Relations: Liolios Group, Inc., Ron Both, Tel: 949 574-3860, TOS@liolios.com; Renmark Financial Communications Inc., Barry Mire, Tel: 416 644-2020 or 514 939-3989, bmire@renmakfinancial.comCopyright CNW Group 2016
TSO3 Accelerates Warrant Expiry Date
View original source (CNW)TSO3 Inc on 6ix
Earlier from TSO3
- TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer
- TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 Sterilizer
- TSO3 Appoints Glen Kayll as Chief Financial Officer
- TSO3 Establishes Medical Industry's First-Ever Claims for Duodenoscope Terminal Sterilization
- TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution Agreement
Later from TSO3
- TSO3 Appoints Harold R. Tessman as COO
- TSO3 Announces $13.5 million in Warrant Proceeds
- TSO3 Provides Operations Update - Recruiting, Supplier Relationships and Improved Process Flow All Contributing to Increased Production Rates and Shipments
- TSO3 Sets Fourth Quarter and Full Year 2015 Earnings Call for Wednesday, March 23, 2016 at 10: 30 a.m. EDT
- TSO3 to Present at the 28th Annual ROTH Conference on March 16, 2016
Follow TSO3 into a list and get an email when it puts out news.
Follow TSO3